article thumbnail

Abstract 4119868: Statin and PCSK9 Inhibitor Utilization and Spending in Medicaid between 2018 to 2022: A National Analysis

Circulation

Introduction:Low-income working-aged adults in the Medicaid program have a high burden of cardiovascular risk factors and disease, but often face barriers accessing necessary therapies. Spending was adjusted for inflation and reported in 2022 US dollars.Results:Medicaid beneficiaries filled 20.4 million in 2022, representing a 0.4%

article thumbnail

Lower Prices For Medicare Drug Negotiation Program’s First 10 Drugs Announced

American College of Cardiology

The Centers for Medicare and Medicaid Services (CMS) on Aug. 15 announced the results of price negotiations for the first 10 drugs selected for the Medicare Drug Negotiation Program, made possible by the passage of the Inflation Reduction Act in 2022.

article thumbnail

Disparities in Postpartum Care After a Hypertensive Disorder of Pregnancy in the United States

Hypertension Journal

Individuals with lower income, lower educational attainment, and those with Medicaid or no insurance were significantly less likely to report attending a postpartum visit. Among those who reported attending a postpartum visit, only 56.3% reported receiving postpartum counseling on healthy lifestyle, 60.9%

article thumbnail

Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

DAIC

In 2022, the American Heart Association report on heart disease statistics estimated that 3 million American adults ages 20 and older have heart failure of reduced ejection fraction with a prevalence expected to increase to more than 4 million people by 2030. CAUTION - Limited by United States law to investigational use.

article thumbnail

Abstract WP48: Prescription Rate for Antihyperglycemic Medication With Proven Cardiovascular Benefit at Discharge in Stroke Patients Not Equal Among Payer Sources

Stroke Journal

21, 2022, from 51 Wisconsin Coverdell Stroke hospitals. Payer sources were identified as: self-pay, Medicaid, Medicare, and Private/HMO. Medicaid, and 15.3% The measure& Antihyperglycemic Medication with Proven Cardiovascular (CVD) Benefit at Discharge in Stroke Patients with DM(AMPB) has low compliance. 1, 2020-Dec.

article thumbnail

Patients Undergo First Doses of New Cardiac PET tracer

DAIC

CAD is the most common form of heart disease and remains the leading cause of death for men and women in the US, with 371,506 deaths reported in 2022 [1]. We are committed to growing the manufacturing footprint for Flyrcado to drive access for cardiac PET-enabled imaging centers throughout the US. National Center for Health Statistics.

article thumbnail

Abstract 079: Preliminary Outcomes of a Survivor?Centric Digital Platform in Stroke Recovery

Stroke: Vascular and Interventional Neurology

The Navigators worked through phone, messaging, and video calls with the stroke survivor and their care partner who had shared access within the app but had separate profiles.

Strokes 40